Editorial Comment from Dr Chapple to Long-term safety and efficacy of the novel β3 -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study
- PMID: 29869398
- DOI: 10.1111/iju.13715
Editorial Comment from Dr Chapple to Long-term safety and efficacy of the novel β3 -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study
Comment on
-
Long-term safety and efficacy of the novel β3 -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study.Int J Urol. 2018 Jul;25(7):668-675. doi: 10.1111/iju.13596. Epub 2018 May 11. Int J Urol. 2018. PMID: 29752752 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical